143 related articles for article (PubMed ID: 9040451)
21. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
22. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
23. [Antihypertensive therapy in chronic kidney disease: what targets and how to reach them].
Bock A
Ther Umsch; 2018; 75(6):365-369. PubMed ID: 30880625
[TBL] [Abstract][Full Text] [Related]
24. Differences between women and men with chronic renal disease.
Coggins CH; Breyer Lewis J; Caggiula AW; Castaldo LS; Klahr S; Wang SR
Nephrol Dial Transplant; 1998 Jun; 13(6):1430-7. PubMed ID: 9641172
[TBL] [Abstract][Full Text] [Related]
25. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.
Jafar TH; Stark PC; Schmid CH; Landa M; Maschio G; Marcantoni C; de Jong PE; de Zeeuw D; Shahinfar S; Ruggenenti P; Remuzzi G; Levey AS;
Kidney Int; 2001 Sep; 60(3):1131-40. PubMed ID: 11532109
[TBL] [Abstract][Full Text] [Related]
26. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
[TBL] [Abstract][Full Text] [Related]
27. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
[TBL] [Abstract][Full Text] [Related]
28. Renal protection and antihypertensive drugs: current status.
Salvetti A; Mattei P; Sudano I
Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
[TBL] [Abstract][Full Text] [Related]
29. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
[TBL] [Abstract][Full Text] [Related]
30. Strict blood-pressure control and progression of renal failure in children.
; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
[TBL] [Abstract][Full Text] [Related]
31. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
Viazzi F; Piscitelli P; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939716
[TBL] [Abstract][Full Text] [Related]
32. Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies.
Cinotti GA; Zucchelli PC;
Nephrol Dial Transplant; 2001 May; 16(5):961-6. PubMed ID: 11328901
[TBL] [Abstract][Full Text] [Related]
33. Amlodipine and loop diuretics as the second anti-hypertensive medication for the treatment of hypertension with chronic kidney diseases.
Takenaka T; Uchida K; Kojima E; Gen S; Nodaira Y; Hoshi H; Kato N; Takane H; Ohno Y; Suzuki H
Clin Exp Hypertens; 2011; 33(4):210-5. PubMed ID: 21699446
[TBL] [Abstract][Full Text] [Related]
34. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
35. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.
Khosla N; Kalaitzidis R; Bakris GL
Am J Nephrol; 2009; 30(5):418-24. PubMed ID: 19738369
[TBL] [Abstract][Full Text] [Related]
36. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
37. Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study.
Hall WD; Kusek JW; Kirk KA; Appel LJ; Schulman G; Agodoa LY; Glassock R; Grim C; Randall OS; Massry SG
Am J Kidney Dis; 1997 May; 29(5):720-8. PubMed ID: 9159306
[TBL] [Abstract][Full Text] [Related]
38. Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease.
Dhaun N; MacIntyre IM; Kerr D; Melville V; Johnston NR; Haughie S; Goddard J; Webb DJ
Hypertension; 2011 Apr; 57(4):772-9. PubMed ID: 21357275
[TBL] [Abstract][Full Text] [Related]
39. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
Hermida RC; Ayala DE; Fernández JR; Mojón A
Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
[TBL] [Abstract][Full Text] [Related]
40. Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial.
Xue C; Zhou C; Yang B; Lv J; Dai B; Yu S; Wang Y; Zhao G; Mei C
BMJ Open; 2017 Feb; 7(2):e013672. PubMed ID: 28237959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
